ImmunityBio (IBRX) Q1 2026 Earnings

23FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.15
-0.12
-0.09
-0.06

Details

Expected EPS
-0.07652
Actual EPS
-0.06
Surprise EPS
0.02
Surprise Percent
+21.59%

Description

ImmunityBio (IBRX) has reported earnings of -0.06 per share for Q1 2026.

0 Comments

Share your thoughts